CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Interferon-alpha and combined with ribavirin in HCV liver transplant recipients: Efficacy and predictors of response
DOI 10.1055/s-2007-967845
Bibliografische Angaben
Nachweis in CareLit
Autor:innenVR Cicinnati, CG Klein, S Iacob, H Baba, G Sotiropoulos, P Hilgard, Y Erim, CE Broelsch, G Gerken, S Beckebaum
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Optimal dose, duration and timing of antiviral treatment of hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) have not been established yet. The identification of factors predictive of response to interferon (IFN) treatment remains a crucial issue in the liver transplant setting. In this prospective study, 26 OLT patients were treated with standard interferon-alpha (IFN-alpha)–2b (2 MU…
Zitieren
Zitierempfehlung
VR Cicinnati, CG Klein, S Iacob, H Baba, G Sotiropoulos, P Hilgard, Y Erim, CE Broelsch, G Gerken, S Beckebaum (2007) Interferon-alpha and combined with ribavirin in HCV liver transplant recipients: Efficacy and predictors of response. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-2007-967845
Mit CareLit weiterarbeiten